Below is a compact, source-backed reference for the Omega-3 market arranged by the headings you requested. I included the most reliable public numbers I could find (market sizes, a few company financials where available) and the top companies named repeatedly across market reports.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Omega-3 market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Omega-3 market.

Read complete report at: https://www.thebrainyinsights.com/report/omega-3-market-13063

Quick market snapshot (selected estimates)

• Global market size (2024) — reports vary by scope (ingredients vs. finished supplements): USD 2.68–3.04B for omega-3 ingredient / fatty-acid market in 2024 (examples: Grand View Research USD 2.82B, DataBridge USD 3.04B, SNS Insider USD 2.68B).

• Omega-3 supplements market (end-product) — larger: Grand View estimates ~USD 7.68B (2024) for supplements specifically. Different reports use different scopes (ingredient concentrate vs finished supplements), so compare definitions. 

Recent developments

• Consolidation & ingredient supplier positioning — several market reports list the same set of major suppliers (ADM, Cargill, DSM-Firmenich, BASF, Aker BioMarine, Croda, Pelagia, Omega Protein, GC Rieber). Market reports (MarketsandMarkets, Mordor, Polaris) highlight these players.

• Krill & algal omega-3 growth — krill (Aker BioMarine, others) and algal oils are rising as alternatives to fish oil for sustainability/vegan positioning. Aker BioMarine reported stable/recorded revenues in 2024 and growth in human-health ingredient sales.

Drivers

• Rising consumer health awareness (cardio, cognitive, infant/ maternal nutrition) and growth of nutraceuticals & functional foods.

• Demand for alternative sources (algal DHA for vegan markets; krill for certain value niches).

• Food-fortification trends and use in pet nutrition & aquaculture increasing ingredient demand.

Restraints

• Supply volatility & raw material constraints (fish oil supply, seasonal catch, regulatory quotas).

• Price variability for concentrates and high-purity EPA/DHA which can limit adoption at lower price tiers.

• Regulatory/health-claim scrutiny — strict substantiation required in many markets for medical/heart-health claims.

Regional segmentation (high-level)

• North America: large supplements market and R&D/clinical trial activity; leads finished-product demand. 

• Europe: strong regulatory focus and demand for sustainable sourcing (krill, certified fish-oil). 

• Asia-Pacific: fast growth in supplements & fortified foods due to rising incomes — large share of volume in many reports.

Emerging trends

• Algal oil (microalgae) expansion — higher interest for vegetarian/vegan DHA sources. 

• Value migration to branded, clinically-supported concentrates (higher-purity EPA/DHA, triglyceride formats, patented formulations).

• Sustainability claims and traceability (certifications, responsible harvesting). 

Top use cases

• Dietary supplements (softgels, liquids, functional gummies). 

• Infant formula and maternal nutrition (DHA fortification). 

• Functional foods & beverages (fortified dairy, spreads). 

• Pet food & aquaculture feed (performance/health benefits). 

Major challenges

• Ingredient price and supply instability, especially for long-chain EPA/DHA concentrates. 

• Differing market definitions across reports (concentrates vs finished products) — makes cross-report comparisons hard. 

• Proving differentiated health claims vs commodity fish oil — costly clinical work.

Attractive opportunities

• Algal DHA for vegan/clean-label segments (higher margins, premium positioning).

• Branded ingredients & clinical substantiation (companies that can supply proven, branded concentrates).

• Geographic expansion in APAC and Latin America where supplement penetration is rising.

Key factors that will expand the market

1. Continued consumer demand for health & preventive nutrition. 

2. Commercial scale-up of algal oil production lowering costs for vegan DHA.

3. Sustainable sourcing & certification reducing supply risk for premium buyers. 

Top companies — references & values (what I could confirm quickly)

The following firms are repeatedly listed across market reports as leading ingredient suppliers / players. Where public numeric values were available I added them; for many large ingredient firms revenue for “omega-3” specifically is reported as a segment or not disclosed separately — in those cases I cite the report that lists them as a top player.

• Aker BioMarine ASA — leading krill oil supplier; Revenue (full year 2024): USD 199.0 million (annual report / Q4 2024 presentation). Aker is often cited as the global leader for krill-based omega-3 ingredients (brands: Superba®/QRILL®).

• DSM-Firmenich (Koninklijke DSM / DSM-Firmenich) — listed as a major supplier in market reports (DSM-Firmenich/Nutrition ingredient capabilities include omega-3 concentrates / branded ingredients). (appears in MarketsandMarkets / Mordor lists). 

• ADM (Archer Daniels Midland) — listed among top ingredient suppliers / processors in multiple reports (ADM supplies oil processing & concentrates). 

• Cargill — named in top-company lists for omega-3 ingredients and supply chain. 

• BASF / Croda / Pelagia / GC Rieber / Omega Protein / Epax (Pelagia/Epax affiliations vary by report) — these companies appear frequently across report vendor lists (Mordor, Polaris, MarketGenics). For many of these, omega-3 is one of several specialty ingredient lines (so companywide revenues are larger than the omega-3 subsegment). 

Note on company values: apart from Aker BioMarine’s public line-item revenues for 2024 (USD 199M), most vendors report only company-level revenues or do not break out omega-3-specific sales in public filings. Market reports rank companies by market presence, product portfolios and estimated market share rather than uniformly published omega-3-only revenue lines. Use company annual reports or investor presentations for the most precise segment numbers when needed.

Sources (selected)

Grand View Research (Omega-3 market size), MarketsandMarkets (top companies list), Aker BioMarine annual report & Q4 presentation (company revenues), DataBridge Market Research, Mordor Intelligence, Polaris Market Research and various market briefs. (Inline citations above point to the specific pages used).

If you’d like, I can now produce a one-page Excel or table that lists the top 10 companies, the source(s) that list them, and any public omega-3 or segment revenue figures I can find (I’ll pull company annual reports/presentations and extract the numbers). Tell me whether you want the output as (A) a spreadsheet table (Excel/CSV), (B) a 1-page PDF / slide, or (C) a simpler ranked list with short notes — and I’ll generate it right away with cited sources.